Table of Contents
- Myth 1: PFP Is a Quadriceps Weakness Problem
- Myth 2: The VMO Must Be Selectively Trained
- Myth 3: PFP Patients Need to Rest Until It Settles
- Myth 4: Gait Retraining Is for Elite Athletes
- Myth 5: Psychological Factors Are Soft and Secondary
- Myth 6: Patellar Taping Is a Primary Treatment
- Myth 7: PFP Is a Benign, Self-Limiting Condition
- Why These Myths Persist
- Frequently Asked Questions
- Which of these patellofemoral pain myths is most consequential to update first?
- Does combined hip and knee strengthening work for adolescents the same way as adults?
- If a runner can't tolerate any running, should I delay gait retraining?
- How do I screen for fear-avoidance without making it feel like I'm calling the patient anxious?
- Does the 46.6% adjacent joint injury number change how aggressively I should treat PFP?
- The Bottom Line
- FAQs
Clinical Summary:
The Gap: Most clinicians still treat PFP using a protocol that is 10+ years out of date. The contemporary evidence rewrites the role of the VMO, the value of rest, the runner's gait, the sentinel-injury status of the diagnosis, and the role of psychological factors.
The Evidence: Halabi (combined strengthening), Anderson & Crossley (gait retraining), Young et al. (46.6% adjacent-joint risk), Selhorst (psychologically informed care), Souto / Abdelhamed / Zheng (NMES adjunct), Gao / Jiao (taping). All within the 2-3 year window.
The Takeaway: The seven myths below are the highest-yield updates to a PFP protocol that's been running on autopilot.
Patellofemoral pain is the most common diagnosis you see in a sports medicine clinic. It accounts for 25 to 40 percent of all knee referrals. It's also the diagnosis with the largest gap between contemporary evidence and standard practice. Most clinicians can still describe the PFP protocol they were taught in school, and most of that protocol no longer holds.
These are the seven patellofemoral pain myths the current evidence most directly refutes. Each one is something a clinician would say in a hallway conversation without anyone batting an eye, and each one now sits against a randomized trial, a systematic review, or a large recent cohort.
Myth 1: PFP Is a Quadriceps Weakness Problem
What clinicians say: "Her quads are weak. We need to build them up and the pain will resolve."
What the research shows: The Halabi systematic review with meta-analysis directly compared hip-focused, knee-focused, and combined strengthening programs. Combined hip and knee strengthening produced superior pain and function outcomes versus knee-only programs. The kinetic chain (hip abductors, hip external rotators, trunk) is at least as relevant as the quadriceps. The Wang meta-analysis on core training adds further support.
Clinical implication: Quad-only programs underperform. Period.
What to do instead: Hip abduction, hip external rotation, trunk stabilization, and knee strengthening from week one, integrated into single-leg functional patterns by week three to four.
The PFP protocol most of us learned was built around the quadriceps because the imaging said so. The kinetic chain evidence finally said otherwise.
Myth 2: The VMO Must Be Selectively Trained
What clinicians say: "Make sure she's firing the VMO. Get those terminal extensions in."
What the research shows: Despite decades of clinical teaching about selective VMO training, general quadriceps strengthening produces equivalent or better outcomes than selective VMO protocols. There is no neuromuscular evidence that VMO can be reliably activated in isolation. The "VMO selective" cue is folklore at this point.
Clinical implication: Time spent on VMO-isolation cuing is time not spent on hip strengthening or gait retraining, which actually move outcomes.
What to do instead: General quadriceps strengthening (squats, step-ups, terminal knee extensions, leg presses) without VMO-specific cueing. Allocate the cueing bandwidth to hip control and lower-extremity alignment instead.
Myth 3: PFP Patients Need to Rest Until It Settles
What clinicians say: "Stop running for a few weeks, ice it, and see if it calms down."
What the research shows: Rest as primary treatment has poor outcomes and high recurrence. Active management with combined strengthening, gait retraining where running is involved, and progressive loading produces better short and long-term function. The 50–60% of patients reporting symptoms at one year are largely the population that rested through it.
Clinical implication: Telling a runner to stop running for six weeks without giving them a structured program is the intervention with the worst long-term track record.
What to do instead: Modify the load (reduce volume and intensity) while introducing combined strengthening and (for runners) cadence retraining. Maintain the activity at a tolerable dose; don't extinguish it.
Myth 4: Gait Retraining Is for Elite Athletes
What clinicians say: "She's a recreational runner, she doesn't need gait analysis."
What the research shows: Anderson & Crossley's systematic review with meta-analysis showed significant pain and function improvements with cadence-based gait retraining across recreational runner populations. De Souza Júnior's RCT directly compared gait retraining plus strengthening to strengthening alone. The combination won. A 7.5 to 10 percent step rate increase, using a metronome app, is a low-tech and immediately accessible intervention.
Cadence Lever:
10%
Step rate increase reduces patellofemoral joint stress and improves PFP outcomes when added to strengthening.
Clinical implication: Cadence work is for the recreational runner more than for the elite. The elite has often already optimized their gait.
What to do instead: Baseline step rate at the patient's typical training pace. Target 7.5 to 10 percent increase. Metronome app. Three to four short, easy runs per week to establish the pattern.
Myth 5: Psychological Factors Are Soft and Secondary
What clinicians say: "Let's get her stronger and her confidence will come back."
What the research shows: The Selhorst RCT on psychologically informed education for adolescents demonstrated significant reductions in fear-avoidance, kinesiophobia, and pain catastrophizing, with corresponding improvements in pain and function. The intervention was video-based and added minimal clinical time. Fear-avoidance predicts outcomes regardless of physical impairment.
Clinical implication: Strengthening alone underperforms when fear-avoidance is elevated. Adding psychologically informed education is one of the highest-leverage and lowest-cost interventions in the PFP toolkit.
What to do instead: Screen with the Tampa Scale of Kinesiophobia or directed clinical interview. Provide pain neuroscience education in plain language. Use graded exposure to feared activities. See the Selhorst trial discussion for the protocol.
Product Spotlight:
Myth 6: Patellar Taping Is a Primary Treatment
What clinicians say: "Tape it up and she can play this weekend."
What the research shows: The Gao and Jiao meta-analyses on kinesiology taping for PFP found short-term pain and function improvements when combined with exercise. Taping alone does not produce durable outcomes. The mechanism likely involves proprioceptive feedback and psychological effects more than mechanical patellar repositioning.
Clinical implication: Taping is a short-term adjunct, not a treatment plan. The patient who is taped weekly without progressive strengthening is the patient who's still symptomatic at one year.
What to do instead: Use taping to enable participation in active rehabilitation, not to replace it. Frame it explicitly as a temporary support.
Neuromuscular electrical stimulation (NMES) has the most consistent evidence among PFP adjuncts. Across the Souto systematic review and the Abdelhamed and Zheng meta-analyses, NMES added to exercise produces superior outcomes for pain and quadriceps strength compared to exercise alone. Among the available adjuncts, it has the best ratio of evidence to clinical effort.
Myth 7: PFP Is a Benign, Self-Limiting Condition
What clinicians say: "She'll grow out of it. Most kids do."
What the research shows: 50–60% of PFP patients report symptoms at one year follow-up, with many persistent for years beyond. Peak incidence is age 13, and adolescent PFP frequently extends into young adulthood. Young et al.'s 92,319-patient analysis found 46.6% of PFP patients sustained an adjacent-joint injury within two years (lumbar, ankle-foot, and hip), and therapeutic exercise for the index PFP reduced that risk.
Clinical implication: PFP is not benign. The "she'll grow out of it" conversation is the wrong conversation. The right one is "this is treatable now, and treating it now reduces the risk of injuries elsewhere."
What to do instead: Treat every PFP presentation as a sentinel for kinetic-chain dysfunction. The combined-strengthening program is preventive, not just therapeutic. See the 46.6% sentinel data for the full picture.
Why These Myths Persist
None of these patellofemoral pain myths are clinical malpractice. They are the previous standard, taught in schools that hadn't yet seen the contemporary evidence. The Halabi meta-analysis, the Selhorst RCT, the Young adjacent-joint cohort, and the Anderson & Crossley gait retraining synthesis are all within the last few years. The clinician who hasn't updated isn't lazy. They haven't been given a forcing function.
That's what makes a CE update worth doing every couple of years on a high-volume diagnosis like PFP. The course pulls the combined-strengthening, gait retraining, psychologically informed, and adjacent-joint findings into one operating model. The deeper hip-plus-knee discussion is in the combined-strengthening evidence blog.
Frequently Asked Questions
Which of these patellofemoral pain myths is most consequential to update first?
The "quadriceps weakness" myth, because it shapes the entire protocol. Once a clinician moves to combined hip-and-knee from week one, the rest of the protocol changes downstream: gait work fits, fear-avoidance screening fits, and the sentinel-injury framing fits. The quad-only paradigm blocks all of those updates.
Does combined hip and knee strengthening work for adolescents the same way as adults?
Yes, with the additional layer of psychologically informed education. The Selhorst RCT in adolescents demonstrated that combining strengthening with pain neuroscience education and graded exposure produces greater improvement in function, pain, and psychological measures than strengthening alone. Both adolescents and adults benefit from the combined approach.
If a runner can't tolerate any running, should I delay gait retraining?
Begin cadence work as soon as the patient can run short, easy distances even at reduced pace. You don't need to wait for full pain resolution. The cadence intervention itself reduces patellofemoral joint stress per step, which often makes return to running more tolerable. Pair with continued combined strengthening.
How do I screen for fear-avoidance without making it feel like I'm calling the patient anxious?
Frame the screening as standard care: "We've learned that how you think about the pain affects how you respond to treatment, so I'm going to ask a few questions." The Tampa Scale of Kinesiophobia takes two minutes. Elevated scores indicate that pain neuroscience education and graded exposure should be added, without implying the symptoms are not real.
Does the 46.6% adjacent joint injury number change how aggressively I should treat PFP?
Yes. The Young et al. finding reframes PFP from a localized knee problem to a kinetic chain marker. Aggressive early therapeutic exercise (combined strengthening, gait work where applicable) lowers the downstream risk. Conservative under-treatment of PFP has costs beyond the knee itself.
The Bottom Line
The seven biggest patellofemoral pain myths all rest on evidence that no longer holds. Quad isolation underperforms combined work. VMO can't be trained selectively. Rest worsens outcomes. Gait retraining works for the recreational runner. Fear-avoidance drives outcomes. Taping is short-term only. And PFP is not benign: it's a sentinel injury. The clinicians who update on these seven points hand their patients a better protocol than the one most of us were taught.
FAQs
Which of these patellofemoral pain myths is most consequential to update first?
The "quadriceps weakness" myth, because it shapes the entire protocol. Once a clinician moves to combined hip-and-knee from week one, the rest of the protocol changes downstream: gait work fits, fear-avoidance screening fits, and the sentinel-injury framing fits. The quad-only paradigm blocks all of those updates.
Does combined hip and knee strengthening work for adolescents the same way as adults?
Yes, with the additional layer of psychologically informed education. The Selhorst RCT in adolescents demonstrated that combining strengthening with pain neuroscience education and graded exposure produces greater improvement in function, pain, and psychological measures than strengthening alone. Both adolescents and adults benefit from the combined approach.
If a runner can't tolerate any running, should I delay gait retraining?
Begin cadence work as soon as the patient can run short, easy distances even at reduced pace. You don't need to wait for full pain resolution. The cadence intervention itself reduces patellofemoral joint stress per step, which often makes return to running more tolerable. Pair with continued combined strengthening.
How do I screen for fear-avoidance without making it feel like I'm calling the patient anxious?
Frame the screening as standard care: "We've learned that how you think about the pain affects how you respond to treatment, so I'm going to ask a few questions." The Tampa Scale of Kinesiophobia takes two minutes. Elevated scores indicate that pain neuroscience education and graded exposure should be added, without implying the symptoms are not real.
Does the 46.6% adjacent joint injury number change how aggressively I should treat PFP?
Yes. The Young et al. finding reframes PFP from a localized knee problem to a kinetic chain marker. Aggressive early therapeutic exercise (combined strengthening, gait work where applicable) lowers the downstream risk. Conservative under-treatment of PFP has costs beyond the knee itself.

